The Medserve-LUTH Cancer Centre (MLCC) has been named the “Most Outstanding Oncology Centre in Nigeria” for the fourth consecutive year.
In a statement on Sunday in Lagos, the hospital said the award was presented at the 12th Nigerian Healthcare Excellence Award (NHEA) on June 26, 2026.
This fourth consecutive win further solidifies MLCC’s reputation as the region’s benchmark for advanced, compassionate, and life-saving cancer care.
As the largest and best-equipped cancer treatment facility in West Africa, MLCC seamlessly integrates cutting-edge technology with clinical expertise. Located within the Lagos University Teaching Hospital (LUTH) in Idi-Araba, Lagos, the centre offers highly specialised, multidisciplinary outpatient care, eliminating the need for patients to seek treatment abroad.
“Securing this honour for four years running is a profound validation of our team’s relentless dedication,” the statement said.
“It reflects our commitment to breaking barriers in cancer treatment, investing in world-class infrastructure, and delivering international-standard care right here in Nigeria.
“Since its inception, the Medserve-LUTH Cancer Centre has transformed the oncology care landscape in West Africa by providing a holistic approach to radiotherapy, chemotherapy, and supportive therapies.
“This four-year streak of national recognition affirms that our model of unified, multidisciplinary care is not only leading the industry but actively shaping the future of cancer survivorship across the region.”
The award ceremony, organised by Global Health Project and Resources in collaboration with the Anadach Group, brought together leading stakeholders in Nigeria’s health sector. The Minister of State for Health and Social Welfare, Dr Iziaq Adekunle Salako, attended as Special Guest of Honour, while the Governor of Lagos State, Mr Babajide Olusola Sanwo-Olu, served as Chief Host.
Dr Muhammed Habeebu, Chief Clinical Coordinator of the Medserve-LUTH Cancer Centre, received the award on behalf of the centre.
The recognition reinforces LUTH’s position as a leading tertiary healthcare institution committed to excellence in specialised care, research, innovation, and patient-centred services. It also highlights the success of the collaboration between LUTH and Medserve in transforming cancer care in Nigeria and the West African sub-region.
The centre’s success is a testament to the commitment of the Federal Government of Nigeria under the Renewed Hope Agenda of President Bola Tinubu, GCFR, in providing quality healthcare to Nigerians.
